Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
In patients with MS, disability, age, and obesity were the main risk factors for COVID-19 of increased severity in a new French study.
The use of disease-modifying therapies did not appear to be associated with increased risk for severe outcome.
This "should reinforce the recommendation of not stopping current disease modifying therapy and not delaying treatment initiation in patients who have higher disease inflammatory activity, risk for relapses, or subsequent disability," the study authors state.
The study was published online in JAMA Neurology on June 26.
The data come from a French registry of COVID-19 cases in patients with MS that was initiated to determine the characteristics of COVID-19 in this population and to identify the risk factors for developing a severe form of this disease. The study included all MS centers in France.
Data were collected on patient demographics, current drug therapy use, Expanded Disability Severity Scale (EDSS) score before COVID-19, comorbidities, and the presence of known lymphopenia before infection.
The primary endpoint was clinical status at the most severe point of SARS-CoV-2 infection (on a 7-point COVID-19 severity score scale), where 1 indicated no hospitalization or limitations on activities and 7 represented death.
A total of 347 MS patients with COVID-19 were included, of whom 73 (21%) had a COVID-19 severity score of 3 or higher (needing hospitalization), and 12 patients (3.5%) died of COVID-19. The median EDSS was 2.0 (range, 0 9.5), and 82% of patients were receiving disease-modifying therapies.
Results showed there was a higher proportion of patients with a COVID-19 severity score of 3 or higher among those who were not taking disease-modifying therapies (46.0% vs 15.5%; P < .001).
But the authors, led by Cline Louapre, MD, L'Institut du Cerveau et de la Moelle pinire, Paris, France, note that disease-modifying therapies are more frequently prescribed for younger patients, those with a relapsing form of MS, and those with a lower level of disability. In a multivariate analysis, no association was found between disease-modifying therapy and COVID-19 severity.
Multivariate logistic regression models determined that age (odds ratio [OR] per 10 years, 1.9); EDSS (OR for EDSS 6, 6.3) and obesity (OR, 3.0) were independent risk factors for a COVID-19 severity score of 3 or higher.
The EDSS was associated with the highest variability of COVID-19 severe outcome, followed by age and then obesity.
Additionally, the multivariate analysis carried out with a COVID-19 severity score threshold of 4 or higher (hospitalized and requiring supplemental oxygen) found male sex to be an independent risk factor for severe COVID-19, as well as age, obesity, and EDSS.
Of the 12 patients who died, most had a progressive form of the disease and a high EDSS.
"The fatality rate among patients who were hospitalized was higher for most age groups in patients with MS compared with the general population in France, suggesting an increased risk of death in patients with MS compared with the general population, which needs to be confirmed with large epidemiological studies," the authors comment.
Four patients were hospitalized in intensive care units but survived. Two received ocrelizumab and had obesity as a comorbidity. A third patient, who had primary progressive MS and was taking rituximab, had an EDSS of 5.5 and had no known comorbidities. The fourth patient had relapsing-remitting MS and was not receiving disease-modifying therapy.
"In this cohort, the exposure to disease modifying therapy and the level of immunosuppression were not factors that independently modified the risk of developing a severe form of COVID-19," the authors say.
However, they add: "Caution should be exercised when interpreting this result, because it is possible that a larger cohort could identify a subgroup of patients with 1 or more DMTs [disease-modifying therapies] that modify the risk of COVID-19. Therefore, the pooling of registries and/or replication of results in other cohorts from several countries will be important to reinforce this result."
Of the two patients who were receiving ocrelizumab and who developed acute respiratory distress syndrome, they write: "Although these 2 patients also had obesity, it cannot be excluded that their disease modifying therapy may have increased their susceptibility to COVID-19 severity."
They stress that serologic studies following SARS-CoV-2 infection will be crucial to determine the characteristics of the immune response with different MS therapies and in particular with anti-CD20 therapies, for which lower immune response to vaccination has been reported.
The researchers say it is "not surprising" that age and obesity were identified as independent risk factors for COVID-19 severity, inasmuch as both of these factors have been identified as major risk factors for adverse outcomes in the general population.
"With the EDSS being the independent variable with the highest explained variability on COVID-19 severity, this finding should lead to strengthening and sustaining precautions and barrier measures to limit the risk of COVID-19 infection in patients with high disability," they say.
Commenting for Medscape Medical News, Jeffrey Cohen, MD, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Ohio, said he thought the study was well done.
"The conclusions largely align with other published (eg, the Italian experience) and not yet published registries and case series and our experience," he noted.
"MS and MS disease-modifying therapies do not appear to have a major effect on susceptibility to infection or risk of poor outcomes from COVID-19. The main risk factors appear to be the same as for the general population (age, male sex, comorbidities, lower socioeconomic status, less distancing) and level of MS-related neurologic disability," Cohen commented.
"In general, we have advised our patients to continue ongoing disease-modifying therapy. When indicated, we have started therapy, though with some consideration of the specific need and risks in the individual patient," he added.
The study did not receive specific funding. Louapre has received consulting or travel fees from Biogen, Novartis, Roche, Sanofi, Teva, and Merck Seronooutside the submitted work.
JAMA Neurol. Published online June 26. Full text
For more Medscape Neurology news, join us on Facebook and Twitter .
Follow this link:
MS Disability, Not Drug Therapy, Tied to Worse COVID-19 Outcomes - Medscape
- Rally for Multiple Sclerosis Treatment Funding - May 7th, 2011 [May 7th, 2011]
- Breakthrough Multiple Sclerosis Treatment? - May 8th, 2011 [May 8th, 2011]
- Multiple Sclerosis Treatment - Mayo Clinic - May 11th, 2011 [May 11th, 2011]
- Tracy Macchia: Controversial MS Treatment - May 14th, 2011 [May 14th, 2011]
- What is Multiple Sclerosis - May 19th, 2011 [May 19th, 2011]
- MS Multiple Sclerosis treatment testimonial from Sanoviv Medical Institute - May 20th, 2011 [May 20th, 2011]
- Patient with progressive ms(paraplegia) Fmr treatment 1/4 - May 22nd, 2011 [May 22nd, 2011]
- New Jersey Multiple Sclerosis Treatment with Chiropractic Care - May 23rd, 2011 [May 23rd, 2011]
- MS Cure - Progression - June 2nd, 2011 [June 2nd, 2011]
- CCSVI UK Multiple Sclerosis Liberation Treatment - June 2nd, 2011 [June 2nd, 2011]
- Stem Cell Therapy MS: Sam Harrell and The Superbowl - June 3rd, 2011 [June 3rd, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach Dallas, TX 2011 - June 8th, 2011 [June 8th, 2011]
- MS treatment sees early success - June 9th, 2011 [June 9th, 2011]
- CCSVI Possible cure for Multiple sclerosis - June 10th, 2011 [June 10th, 2011]
- MS Cure - Introduction to stem cell bone marrow transplant in Australia - June 11th, 2011 [June 11th, 2011]
- (Multiple Sclerosis Cure) Change Your Thinking? (Multiple Sclerosis Cure) - June 12th, 2011 [June 12th, 2011]
- Essiac cancer treatment herbal tincture, Ms Caisse...from The Secrets of Eden - June 12th, 2011 [June 12th, 2011]
- MS walking treatment breakthrough - June 14th, 2011 [June 14th, 2011]
- multiple sclerosis natural treatment | Kathy Canada Testimonial - June 18th, 2011 [June 18th, 2011]
- CCSVI Surgery India - Liberation Procedure Multiple Sclerosis Treatment in India - June 29th, 2011 [June 29th, 2011]
- XCell-Center MS CCSVI Liberation Angioplasty Treatment Results E.Schuurman 18_01_11 - July 1st, 2011 [July 1st, 2011]
- MS Cure - 7PM Project Carmel Turner MS Stem Cell Treatment - July 9th, 2011 [July 9th, 2011]
- MS Update! Tysabri or Gilenya? - July 10th, 2011 [July 10th, 2011]
- What causes BSE, CJD - July 15th, 2011 [July 15th, 2011]
- Kath Bartlett, MS, LAc Balance Method Acupuncture - July 16th, 2011 [July 16th, 2011]
- MS Cure - 730 report ben leahy carmel turner ms stem cell treatment - July 17th, 2011 [July 17th, 2011]
- CCSVI LIberation Treatment Tokuda - July 18th, 2011 [July 18th, 2011]
- FOX News Interview on the O'Reilly Factor - Treatment of Women in Islam - July 18th, 2011 [July 18th, 2011]
- CCSVI treatment bloopers holy crap - July 18th, 2011 [July 18th, 2011]
- Tarah's CCSVI Venoplasty. Dr McGuckin Explaining procedure findings - July 19th, 2011 [July 19th, 2011]
- Cancer Cure: The One-Minute Cure For Cancer, MS - July 24th, 2011 [July 24th, 2011]
- Not Ready to Cheer CCSVI Trials - July 29th, 2011 [July 29th, 2011]
- New Oral Treatment for MS - July 30th, 2011 [July 30th, 2011]
- 27/07/2011 - MS patients seek controversial treatment - August 1st, 2011 [August 1st, 2011]
- MS Cure - 11 I am still walking - August 5th, 2011 [August 5th, 2011]
- Upcoming Treatments for MS - Pt 1 -MSRA Public Lecture - Dr Suzanne Hodgkinson - August 10th, 2011 [August 10th, 2011]
- Stem Cells for MS Community Outreach: Patient Judi Lecoq - Dallas, TX 2011 - August 18th, 2011 [August 18th, 2011]
- Stem Cell Treatment for Multiple Sclerosis - Community Outreach, San Diego: David Oliver - August 19th, 2011 [August 19th, 2011]
- New Study Tests Possible Treatment for MS - August 25th, 2011 [August 25th, 2011]
- Professor Dimitrios Karussis: Treating MS - August 26th, 2011 [August 26th, 2011]
- walking with MS before CCSVI treatment.wmv - August 27th, 2011 [August 27th, 2011]
- Suzy Cohen Discusses The Liberation Treatment for MS - September 14th, 2011 [September 14th, 2011]
- Multiple Sclerosis MS People - Amazing New Treatment - September 15th, 2011 [September 15th, 2011]
- Multiple Sclerosis Alternative Treatment - September 17th, 2011 [September 17th, 2011]
- CLEAR scoliosis treatment, Dr. Culpepper (MS) - September 22nd, 2011 [September 22nd, 2011]
- Liberation treatment for MS - September 23rd, 2011 [September 23rd, 2011]
- 44b - My Lyme disease and rheumatoid arthritis journey - Miraculous CCSVI treatment for MS sufferers - September 24th, 2011 [September 24th, 2011]
- A Closer Look at Gilenya - The First Oral Treatment for MS - September 28th, 2011 [September 28th, 2011]
- Unequal Treatment Drives Disability Rights Movement - September 28th, 2011 [September 28th, 2011]
- Multiple Sclerosis - The Nebraska Medical Center - September 29th, 2011 [September 29th, 2011]
- Testimonial for CCSVI Treatment Excel Heart Center Mexico -- Tanya Reay - September 30th, 2011 [September 30th, 2011]
- Current thinking on what causes MS - Pt 1 - MSRA Public Lecture -Prof Graeme Stewart - October 2nd, 2011 [October 2nd, 2011]
- Current and emerging therapies in MS - Part 02 (How do these treatments work?) - October 2nd, 2011 [October 2nd, 2011]
- MS Richard Humphries before and after treatment for Multiple Sclerosis with stem cells - October 3rd, 2011 [October 3rd, 2011]
- Matthew - CCSVI and his Liberation Treatment - October 8th, 2011 [October 8th, 2011]
- Multiple Sclerosis - Myelin Repair - Video - October 14th, 2011 [October 14th, 2011]
- MS Auto Immune vs CCSVI Treatment Simple Pictures by Berukoff - Video - October 23rd, 2011 [October 23rd, 2011]
- New Promising Treatment for Those Living with Multiple Sclerosis - Video - October 29th, 2011 [October 29th, 2011]
- Stem cells to treat MS - Pt 2 - MSRA Public Lecture - A/Prof Richard Burt - Video - October 30th, 2011 [October 30th, 2011]
- New hope for treating multiple sclerosis - Video - October 31st, 2011 [October 31st, 2011]
- CCSVI Multiple sclerosis Breakthrough/cure - Video - October 31st, 2011 [October 31st, 2011]
- Inhuman Treatment of Wheelchair bound Multiple Sclerosis Patient in Canadian Care Home - Video - November 9th, 2011 [November 9th, 2011]
- MS treatment movie Cells4health.mp4 - Video - November 10th, 2011 [November 10th, 2011]
- Racing to the Cure for MS: Myelin Repair Foundation Celebrates MS Awareness Week - Video - November 12th, 2011 [November 12th, 2011]
- [Symptoms of Multiple Sclerosis] - Video - November 12th, 2011 [November 12th, 2011]
- Multiple Sclerosis Treated with Adult Stem Cells - Video - November 13th, 2011 [November 13th, 2011]
- Stem cells to treat MS - Pt 1 - MSRA Public Lecture - A/Prof Richard Burt - Video - November 16th, 2011 [November 16th, 2011]
- Multiple Sclerosis A Natural Treatment - Video - November 16th, 2011 [November 16th, 2011]
- My MS and Stem Cell Treatment - Video - November 16th, 2011 [November 16th, 2011]
- CCSVI Liberation News Reports - Video - November 20th, 2011 [November 20th, 2011]
- Stem Cells for MS Community Outreach: Patient Sam Harrell - Dallas, TX 2011 - Video - November 21st, 2011 [November 21st, 2011]
- Arthur S13 E2-1 - The Silent Treatment - Video - November 27th, 2011 [November 27th, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach San Diego CA - Video - December 3rd, 2011 [December 3rd, 2011]
- CCSVI - Video - December 3rd, 2011 [December 3rd, 2011]
- My Sister's Experience with Liberation Treatment for Multiple Sclerosis PART 2/2 - Video - December 5th, 2011 [December 5th, 2011]
- Multiple Sclerosis -- Treatment LDN story - Video - December 7th, 2011 [December 7th, 2011]
- ABC News - Multiple Sclerosis effectively treated by a new acoustic medical device. - Video - December 9th, 2011 [December 9th, 2011]
- MS Patient After Stem Cell Therapy - Video - December 10th, 2011 [December 10th, 2011]
- Multiple Sclerosis - Video - December 12th, 2011 [December 12th, 2011]
- Journey of Connective Tissue, Autoimmune disease, steroid treatment updates. - Video - December 22nd, 2011 [December 22nd, 2011]